title: C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem.
abstract: We investigated the unusual susceptibility to meropenem observed for seven imipenem-resistant clinical isolates of Pseudomonas aeruginosa. These strains were genetically closely related, expressed OprD, as determined by Western blot analyses, and were resistant to imipenem (>5 microg/ml) but susceptible to meropenem (<1 microg/ml). The oprD genes from two isolates were entirely sequenced, and their deduced protein sequences showed 93% identity with that of OprD of strain PAO1. The major alteration consisted of the replacement of a stretch of 12 amino acids, located in putative external loop L7 of OprD, by a divergent sequence of 10 amino acid residues. The oprD gene variants and the wild-type oprD gene were cloned and expressed in a defined oprD mutant. The meropenem MICs for strains carrying the oprD genes from clinical isolates were four times lower than that for the strain carrying the wild-type oprD gene. Imipenem activities, however, were comparable for all strains. Furthermore, meropenem hypersusceptibility was obtained with a hybrid OprD porin that consisted of the PAO1 oprD gene containing loop L7 from a clinical isolate. These results show that the C-terminal portion of OprD, in particular, loop L7, was responsible for the unusual meropenem hypersusceptibility. Competition experiments suggested that the observed OprD modifications in the clinical isolates did not affect antagonism between imipenem and the basic amino acid L-lysine. We further propose that shortening of putative loop L7 of the OprD porin by 2 amino acid residues sufficiently opens the porin channel to allow optimal penetration of meropenem and increase its activity. In contrast, this alteration would not affect susceptibility to a smaller carbapenem molecule, such as imipenem.
authors.affiliation: Département de Génétique et Microbiologie, Centre Médical Universitaire, 1211 Geneva 4, Switzerland.
authors.forename: S F
authors.initials: SF
authors.lastname: Epp
authors.forename: T
authors.initials: T
authors.lastname: Köhler
authors.forename: P
authors.initials: P
authors.lastname: Plésiat
authors.forename: M
authors.initials: M
authors.lastname: Michéa-Hamzehpour
authors.forename: J
authors.initials: J
authors.lastname: Frey
authors.forename: J C
authors.initials: JC
authors.lastname: Pechère
mesh_terms: D000595:Amino Acid Sequence; D015378:Imipenem / Q000494:pharmacology*; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D010957:Plasmids / Q000187:drug effects; D018272:Porins / Q000187:drug effects*; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000235:genetics*; D013845:Thienamycins / Q000494:pharmacology*
chemical_list: D018272:Porins; D013845:Thienamycins; C077157:OprD protein, Pseudomonas aeruginosa; D015378:Imipenem; D000077731:Meropenem